期刊文献+

慢性心力衰竭患者血清CA125测定的临床意义

下载PDF
导出
摘要 目的探讨慢性心力衰竭(CHF)患者血清糖类抗原125(CA125)与心功能之间的关系。方法 62例(男38例、女24例)CHF患者根据纽约心功能分级标准分为Ⅱ级、Ⅲ级、Ⅳ级组;根据左室射血分数(LVEF)值分为≥50%组、49%~35%组、≤35%组。另选正常对照组20例(男8例、女12例)。采用微粒子酶免疫化学发光法(META)测定血清CA125水平,超声心动图测定LVEF。结果 CHF患者各组血清CA125水平随心功能恶化程度的增加而升高,心功能Ⅱ级为(22.84±11.48)U/mL,Ⅲ级为(50.65±26.88)U/mL,Ⅳ级为(185.46±105.60)U/mL,均较对照组(9.64±3.06)U/mL升高(P<0.05),各组间比较差异有统计学意义(P<0.05);随着LVEF的降低,血清CA125水平升高。结论慢性心力衰竭患者血清CA125升高,其变化程度对评价心功能程度有一定的参考价值。
出处 《中西医结合心脑血管病杂志》 2012年第9期1057-1058,共2页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
  • 相关文献

参考文献7

  • 1无.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095. 被引量:3700
  • 2Bast RJ,Feeney M,Lazarus H. Reactivity of a monoclonal antibodywith human ovarian carcinoma [J], J Clin Invest , 1981 * 68 ( 5):1331 - 1337.
  • 3Nagele H.BahloM,Klapdor R,eZ al. CA125 and its relation to car-diac function[J], Am Heart J , 1999 ,137(6) : 1044 - 1049.
  • 4王一波,金美玲,沈卫峰.血清CA125水平与充血性心力衰竭关系初探[J].临床内科杂志,2006,23(2):99-101. 被引量:23
  • 5Ahokas RA, Sun Y, Bhattacharya SK.er al. Aldos teronism and aproinflammatory vascular phenotype: Role of .Mg2+,Ca2+ . andH2O2 in peripheral blood mononuclear cells[J]. Circulation, 2005 ,111(1):51-57.
  • 6Duman C, Ercan E,Tengiz \,et al. Elevated serum CA125 levels inmitral stenotic patinets with heart failure[J]. Cardiology,2003,100(1):7-10.
  • 7Yamazaki T,Komurol, Yazaki Y. Molecular mechanism of cardiac-cellular hypertrophy by mechanical stress[J]. J Mol Cell Cardiol,1995,27:133.

二级参考文献47

  • 1王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:91
  • 2Keulenaer G, Brutsaert D. Pathogenesis of heart failure changing conceptual paradigms. Acta Cardiol,1998,53:131-141.
  • 3The Criteria Committee of New York Heart Association. 1994 revisions to classification of functional capacity and objective assessment of patients with disease of the heart. Circulation, 1994,90:644-645.
  • 4Nagele H, Marlies Bahol, Rainer Klapdor, et al. CA125 and its relation to cardiac function. Am Heart J, 1999,137 : 1044-1049.
  • 5Deleeuw PW,kroon AA. Hypertersion and the development of heart failure. Cardiovasc Pharmacol, 1998,32:9-15.
  • 6Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol, 1997, 80(11A) : 15L-25L
  • 7Braunwald E,Bristow MR Congestive heart failure: fifty years of progress. Circulation, 2000, 102(20 Suppl 4) : Ⅳ14-23.
  • 8Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) : developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation, 2005, 112 (12) :e154-235.
  • 9Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary ( update 2005 ):The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26(11): 1115-1140.
  • 10Arnold JM, Liu P, Demers C, et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006 : diagnosis and management. Can J Cardiol, 2006, 22 (1): 23-45.

共引文献3720

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部